Company Search:
Advanced Search
Sponsored Links
Reata Pharmaceuticals Inc Company Snapshot
Reata Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Reata Pharmaceuticals Inc with three other companies in this sector in the United States: Achaogen Inc (2016 sales of $41.77 million of which 100% was Biopharmaceutical), Applied Genetic Technologies Corp ($47.36 million ), and Aduro Biotech Inc ($50.68 million of which 100% was ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Reata Pharmaceuticals Inc
  Stock Performance Chart for Reata Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 28.43
(Figures in U.S. Dollars)
1 Week 5.0%   13 Weeks 13.3%  
4 Weeks -14.3%   52 Weeks 23.5%  
Reata Pharmaceuticals Inc Key Data:
  Ticker: RETA Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 49,856,000
(Year Ending Jan 2017).
Employees: 75
  Currency: U.S. Dollars Market Cap: 742,434,354
  Fiscal Yr Ends: December Shares Outstanding: 26,114,469
  Share Type: Ordinary Closely Held Shares: 11,101,871
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.